Harbor Capital Advisors, Inc. Legend Biotech Corp Transaction History
Harbor Capital Advisors, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 6,441 shares of LEGN stock, worth $243,727. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,441
Previous 10,593
39.2%
Holding current value
$243,727
Previous $516,000
59.3%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
73.7MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$423 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$284 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$251 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$216 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$191 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.33B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...